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STUDIES OF HYPOXEMIC/ 
REOXYGENATION INJURY: 
WITH AORTIC CLAMPING 
X. Exogenous antioxidants 
to avoid nullification of the 
cardioprotective ffects of 
blood cardioplegia 
This study tests the hypothesis that reoxygenation f cyanotic immature hearts 
when starting cardiopulmonary b pass produces an "unintended" reoxygen- 
ation injury that (1) nullifies the cardioprotective effects of blood cardioplegia 
and (2) is avoidable by adding antioxidants N-(2-mercaptopropionyl),glycine 
plus catalase to the cardiopulmonary b pass prime. Twenty immature piglets 
(2 to 3 weeks) underwent 30 minutes of aortic clamping with a blood car- 
dioplegic solution that was hypocalcemic, alkalotic, hyperosmolar, and en- 
riched with glutamate and aspartate during 1 hour of cardiopulmonary bypass. 
Of these, six piglets did not undergo hypoxemia (blood cardioplegic control) 
and 14 others remained hypoxemic (oxygen tension about 25 mm Hg) for up to 
2 hours by lowering ventilator f action of inspired oxygenbefore reoxygenation 
on cardiopulmonary b pass. The primary solution of the cardiopulmonary 
bypass circuit was unchanged in eight piglets (no treatment) and supple- 
mented with the antioxidants N-(2-mercaptopropionyl)-glycine (80 mg/kg) and 
catalase (5 mg/kg) in six others (N-(2-mercaptopropionyl)-glycine and cata- 
lase). Myocardial function (end-systolic elastance), lipid peroxidation (myo. 
cardial conjugated iene production), and antioxidant reserve capacity were 
evaluated. Blood cardioplegic arrest produced no biochemical or functional 
changes in nonhypoxemic control piglets. Reoxygenation caused an approxi- 
mate 10-fold increase in conjugated production that persisted throughout 
cardiopulmonary b pass, lowered antioxidant reserve capacity 86% + 12%, 
and produced profound myocardial dysfunction, because nd-systolic elas- 
tance recovere d only 21% - 2%. Supplementation f the cardiopulmonary 
bypass prime with N,(2.mercaptopropionyl)-glycine and catalase reduced lipid 
peroxidation, restored antioxidant reserve capacity, and allowed near complete 
functional recovery (80% - 8%).** Lipid peroxidation ,(conjugated iene) 
production was lower during warm blood Cardioplegic reperfusion than during 
induction in all reoxygenated hearts, which suggests that blood cardioplegia 
did not injure reoxygenated myocardium. We conclude that reoxygenation f 
the hypoxemic immature heart causes cardiac functional and antioxidant 
damage that nullifies the cardioprotective effects of blood cardioplegia that can 
be avoided by supplementation f the cardiopulmonary b pas  prime with 
antioxidants (*p < 0.05 vs blood cardioplegic control; 17 < 0.05 vs reoxygen- 
ation). (J TnORAC CARDIOVASC SURG 1995;110:1245-54) 
Kiyozo Morita, MD, a Kai Ihnken, MD, a Gerald D. Buckberg, MDfl 
Georg Matheis, MD, a Michael P. Sherman, MD, b and 
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B lood cardioplegia (BCP) is reportedly less car- dioprotective in cyanotic than in noncyanotic 
patients, 1 presumably because hypoxemic immature 
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hearts are more susceptible to ischemic/reperfusion 
injury.2, 3 This vulnerability may in part account for 
the early ventricular dysfunction after successful 
anatomic orrection of cyanotic ongenital defects 4 
and the higher morbidity and mortality than in 
nonhypoxemic adult patients. 5-7 Our recent stud- 
ies s, 9 focus on the deleterious cardiac effects of 
restoring molecular oxygen by initiating cardiopul- 
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monary bypass (CPB) in previously hypoxemic im- 
mature hearts. Myocardial damage occurred in the 
absence of ischemic/reperfusion stress (aortic 
clamping); this was interpreted to suggest hat an 
unintended surgical reoxygenation i jury develops 
in the cyanotic myocardium at the onset of routine 
CPB. Reoxygenation-induced myocardial depres- 
sion was characterized by lipid peroxidation and 
reduced cardiac antioxidant reserve capacity and 
occurred independent of the method of causing 
hypoxemic/reoxygenation stressJ ° These observa- 
tions in the acute hypoxemic model are consistent 
with clinical reports showing myocardial lipid 
peroxidation and reduced antioxidant enzyme ac- 
tivity (glutathione perox idase) in  preischemic 
myocardial biopsy samples from cyanotic hildren 
placed on CPB. TM 12 The aforementioned experi- 
mental and clinical findings led us to hypothesize 
that this initial oxidant injury may become addi- 
tive to subsequent intraoperative oxidative stress 
(i.e., aortic clamping) and compound post-CPB dys- 
function during surgical repair of congenital defects 
causing cyanosis. 
Superoxide anion (02) ,  hydrogen peroxide 
(H202), and hydroxyl ion (.OH) are reactive oxygen 
intermediates. Of these, .OH is the most cytotoxic 
that causes lipid peroxidation and protein thiol 
oxidation, 13 which leads to myocardial and endo- 
thelial cell injury on reoxygenation. TM 15 Hydroxyl 
radical may be produced through both the iron- 
catalyzed Haber-Weiss reaction 16 and the L-arginine- 
nitric oxide pathway8 and may have other deleteri- 
ous consequences, a7'ls Our prior studies show 
hypoxemia/reoxygenation damage without associated 
aortic clamping can be limited by priming the extra- 
corporeal circuit with the exogenous antioxidant N-(2- 
mercaptopropionyl)-glycine, which i s a powerful scav- 
enger of .OH 14' 15 and hypochlorous acid [HOC1], 17 
and catalase, which scavenges H202 .19 
This study incorporates an interval of aortic 
clamping to simulate the ischemic/reperfusion stress 
coincident with surgical repair of lesions causing 
cyanosis in immature hearts. Myocardial manage- 
ment was with a hypocalcemic, alkalotic, glutamate/ 
aspartate-enriched BCP solution shown previously 
to restore mechanical function to energy-depleted 
hearts subjected to regional and global ischemia/ 
reperfusion injury in the experimental 2° and clin- 
ical setting. 21 Its safety in hypoxemic immature 
puppy hearts is established, 22but its cardioprotec- 
tive capacity in the porcine myocardium (which 
closely simulates the human heart 23) and its abil- 
ity to restore metabolism and function to myocar- 
dium subjected hypoxemic/reoxygenation are un- 
proved. 
These experiments in an in vivo piglet model of 
hypoxemia with subsequent reoxygenation on CPB 
and aortic clamping with BCP were done to test the 
hypotheses that (1) a brief interval (5 minutes) of 
reoxygenation at the initiation of bypass causes 
sufficient myocardial injury to nullify the cardiopro- 
tective effects of BCP, and (2) these deleterious 
reoxygenation changes can be offset by adding N-(2- 
mercaptopropionyl)-glycine amd catalase to the 
priming fluid of the extracorporeal circuit. 
Material and methods 
Experimental model. Twenty-five immature, 2- to 3- 
week-old Yorkshire-DUroc piglets (3 to 5 kg) were pre- 
medicated with 0.5 mg/kg diazepam intramuscularly, anes- 
thetized with 30 mg/kg pentobarbital intraperitoneally 
followed by 5 mg/kg intravenously each hour, and the 
lungs ventilated on a volume-limited respirator (Servo 
900D, Siemens-Elema, Solna, Sweden) via a tracheos- 
tomy. All animals received humane care in compliance 
with the "Principles of Laboratory Animal Care" formu- 
lated by the National Society for Medical Research and 
the "Guide for the Care and Use of Laboratory Animals" 
prepared by the National Academy of Sciences, published 
by the National institutes of Health (NIH Publication No. 
86-23, revised 1985). The surgical preparation, including 
vessel cannulation for CPB and placement of the catheter 
for monitoring and blood sampling and prime of the CPB 
circuit, is similar to that reported previously. 1° 
Physiologic and biochemical determinations. Hemody- 
namic measurements were made before the start of 
hypoxemia (control), every 15 minutes during hypoxemia, 
and 15 and 30 minutes after discontinuation of CPB. 
Cardiac output was determined by duplicate injections of 
1 ml of 4°C cold saline 'solution into a central venous 
catheter. Cardiac index (CI), systemic vascular resistance 
index (SVRI), pulmonary vascular resistance index 
(PVRI), and left ventricular stroke work index (LVSWI) 
were calculated with the following equations: 
CI (ml/min/kg) = CO/body weight (kg) 
SVRI (mm Hg • min • L- 1 . kg) = (MAP - CVP) 
(mm Hg) • CO ~ (L/min) • BW (kg) 
PVRI (ram Hg • min • L-  ~ • kg) = (PAP - LAP) 
(mm Hg). CO - 1 (ml/min) • BW (kg) 
LVSWI (g • m/kg) = (MAP - LAP) × CO (ml/min) 
× 0.0136/(HR × body weight [kg]) 
where MAP is mean aortic pressure, PAP is mean pulmo- 
nary artery pressure, LAP is mean left atrial pressure, 
CVP is central venous pressure, CO is cardiac 6utpflt in 
milliliters per minute, and HR is heart rate. 
Left ventricular (LV) performance was evaluated by 
inscribing pressure-volume loops with an LV five-elec- 
trode conductance atheter as described previously, and 
CO was determined by duplicate injections of 1 m! of 4 ° C 
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Table. Hemodynamic parameters during hypoxia and reoxygenation 
Hypoxia Hypoxia 
Control (15 rain) (30 rain) End hypoxia 15 rnin off CPB 30 rain off CPB 
CI (ml/min/kg) 
Reox + BCP 118 _+ 6 95 -+ 28 117 _+ 21 109 _+ 27 68 _+ 9 85 _+ 14 
+ MPG/CAT 132 _+ 19 128 -+ 29 102 _+ 33 129 ± 36 98 _+ 30 99 ± 15 
SWI (g × m/kg) 
Reox + BCP 0.49 ± 0.07 0.40 ± 0.13 0.38 ± 0.10 0.39 ± 0.08 0.14 _+ 0.04 0.21 _+ 0.04 
+ MPG/CAT 0.51 _+ 0.11 0.37 ± 0.12 0.40 _+ 0.14 0.34 _+ 0.15 0.35 ± 0.05* 0.36 _+ 0.06* 
SVRI (ram Hg. rain. L -a • kg) 
Reox + BCP 537 ± 44 441 ± 73 388 ± 70 348 -- 62 544 _+ 95 571 ± 139 
+ MPG/CAT 434 ± 47 342 ± 50 333 ± 48 332 _+ 24 367 _+ 71 387 _+ 45 
PVRI (mm Hg. min. L 1. kg) 
Reox + BCP 72 ± 8 264 _+ 34 203 _+ 24 180 _+ 11 289 ± 64 312 _+ 53 
+ MPG/CAT 70 ± 13 230 -+ 45 177 +_ 35 177 ± 45 131 ± 40 124 + 36* 
Reox + BCP, All piglets were reoxygenated onCPB and received BCP; +MPG/CAT, those piglets reoxygenated onCPB, receiving BCP, where the priming 
fluid of the CPB circuit was supplemented with mercaptropropionylglycine (80 mg/kg) and catalase (50,000 units/kg). 
*p < 0.05 versus reoxygenation + BCP. (Reox + BCP) 
saline solution into the right )atrium through a thermodi- 
lution probe placed into tile main pulmonary artery and 
connected to a cardiac computer (Model 9520A, Ameri- 
can Edwards Laboratory, Santa Ana, Calif.). Results were 
expressed as stroke work index (SWI) in g × m/kg to 
normalize for body weight. 
Myocardial oxidant injury 
Plasma conjugated ienes. Hydroxy conjugated iene 
(CD) concentration in coronary artery and coronary sinus 
blood was determined as described by Lefnesky and 
coworkers. 24 
CD production. Aliquots of coronary artery perfusate 
(BCP) and coronary venous effluent were sampled to 
determine CD production. CD production was calculated 
by the following formula; CBF (V - A)/100 gm fieart 
weight, where A and V ate the concentration f CDs in 
the BCP perfusate and eoronary sinus effluent respec- 
tively, and coronary blood flow (CBF) is the BCP flow rate 
in milliliters per minute. 
Antioxidant reserve capacity. We assessed the myocar- 
dial antioxidant state in vitro by incubating myocardial 
homogenates with 0 to 4 mmol of the oxidant -butylhy- 
droperoxide for 30 minutes as described previously by 
Godin and colleaguesY 
Protocol for BCP myocardial management. The BCP 
formulation was developed experimentally 26" 27 and is 
used clinically. 28' 29 The BCP protocol included induction 
With warm cardioplegia (37 ° C) for 3 minutes followed b~ 
cold cardioplegia for 2 niinutes (4 ° C), and a 3-mintit~ 
reperfusion with 37 ° C BCP just before aortic unclamping. 
Infusion rate was regulate~t by calibrated roller pump at 
10 ml/min/kg initially to produce arrest and 5 ml/min/kg 
thereafter with aortic pressure averaging about 50 mm 
Hg. 
Experimental groups 
Nonhypoxemic studies. Five normoxemic piglets were 
ar~esthetized, instrumented, and observed over 5 hours 
without CPB to provide control hemodynamic and bio- 
chemical data. SIX other piglets underwent CPB at oxygen 
tension (Po2) about 400 mm Hg and BCP arrest without 
preceding hypoxemia. 
Hypoxemic/reoxygenation s udies. Fourteen piglets were 
made hypoxemic by lowering inspired oxygen fraction 
(Fio2) to 6% to 7% to reduce Po2 to about 25 mm Hg for 
up to 120 minutes, followed by reoxygenation CPB at 
Po2 about 400 mm Hg, and 30 minutes of BCP arrest. The 
aorta was clamped 5 minutes after CPB was started to 
simulate what is done clinically. Reoxygenation before 120 
minutes was begun if either mean arterial pressure fell 
below 30 mm Hg and was unresponsive to volume infusion 
or arterial pH could not be kept above 7.3 by three bolus 
intravenous infusions of NaHCO3. 
Hypoxemic/Reoxygenation without treatment studies 
(Reox + BCP). Eight piglets underwent the aforemen- 
tioned protocol without changing the priming fluid in the 
extracorporeal circuit. 
~-(2-mercaptopropionyl)-glycine and catalase. In six pig- 
lets the priming fluid of the CPB circuit was supplemented 
with N-(2-mercaptopropionyl)-glycine (80 mg/kg) plus 
catalase (50,000 units/kg/L). 
Statistics. Data were analyzed with the use of the 
StatView V2.0 program (Abacus Concepts Inc., Berkeley, 
Calif.) on a Macintosh IIci computer (Apple, Inc., Cuper- 
tino, Calif.). Analysis of variance was used for intergroup 
comparison, and the paired Student test was used for 
comparison of variables within experimental groups. The 
relationship between functional impairment (percent Ees) 
and lipid peroxidation (CDs) was tested by linear regres- 
sion analysis. Differences were considered significant at 
the probability level of p < 0.05. Group data were 
expressed as mean plus or minus standard error of the 
mean. 
Results 
Hemodynamie results. All hemodynamic vari- 
ables remained stable during 5 hours of observation 
in instrumented piglets that did not undergo CPB, 
and pre- and post-CPB measurements were compa- 
rable after 60 minutes of CPB, including 30 minutes 
of aortic clamping with BCP. The Table shows the 
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Fig. 1. Recovery of LV contractility, expressed as percent of control end-systolic elastance (Ees) in 
nonhypoxemic piglets receiving BCP, after reoxygenation (Re02) followed by BCP, and when MPG and 
CAT were added to the extracorporeal circuit prime before CPB was started (see text for description). *p < 
0.05 vs BCP and MPG/CAT; tp < 0.05 vs ReO 2 + BCP. 
hemodynamic changes during control, hypoxemia, 
and after CPB was discontinued in piglets undergo- 
ing hypoxemia nd reoxygenation  CPB and BCP 
management. The response to hypoxemia was sys- 
temic vasodilatation and pulmonary vasoconstric- 
tion, and the mean duration of hypoxemia was 76 
minutes _+ 11 minutes and 72 minutes _+ 13 minutes, 
respectively, in piglets reoxygenated on bypass with 
the unmodified priming fluid (no treatment) and 
when the CPB prime was supplemented with MPG/ 
CAT. Premature start of CPB because of hemo- 
dynamic deterioration was needed in 10 of 14 
piglets. 
LVSWI was calculated after transfusion to LAP 
8 mm Hg before and after CPB, and recovered 
completely in nonhypoxemic piglets. Conversely, 
LVSWI recovered only 42% in untreated piglets but 
returned to 70% of CPB values when N-(2-mercap- 
topropionyl)-glycine and catalase was added to the 
CPB prime (p < 0.05). However, CIs were similar in 
both groups, but SVRI was slightly lower after N-(2- 
mercaptopropionyl)-glycine and catalase treatment. 
LV performance. Complete functional recovery 
occurred in nonhypoxemic piglets managed by BCP 
during 30 minutes of aortic clamping. Conversely, 
end-systolic elastance (Ees) recovered only 21% _+ 
2% (p < 0.05 vs BCP, Fig. 1) after reoxygenation  
CPB before application of the same BCP regimen. 
Post-CPB recovery of Ees was 80% _+ 8% with this 
myocardial management method during aortic 
clamping when CPB was initiated with a prime 
containing N-(2-mercaptopropionyl)-glycine and 
catalase (p < 0.05 vs reoxygenation plus CPB). 
PVR/. PVRI remained unchanged during the 
5-hour observation period but increased 156% in 
nonhypoxemic piglets subjected to 60 minutes of 
CPB (213 + 30vs 83 + 12mm Hg-min. L -1 .kg, p < 
0.05 vs control) and rose 345% in piglets reoxygenated 
on CPB (312 _+ 53 mm Hg. min. mL -1. kg, p < 0.05 
vs reoxygenation and BCP). The lowest post-CPB 
PVRI occurred when N-(2-mercaptopropionyl)-gly- 
cine and catalase were added to the CPB prime, with 
values returning to near control evels (Fig. 2). 
Oxidant damage. Coronary sinus conjugated 
dienes remained normal, and no CD production 
occurred in nonhypoxemic piglets undergoing CPB 
with 30 minutes of BCP management. In contrast, 
CD production increased 10-fold during cardiople- 
gic induction and persisted to a lesser extent during 
reperfusion after reoxygenation CPB (Fig. 3) and 
returned to normal toward the end of CPB. The 
addition of N-(2-mercaptopropionyl)-glycine a d
catalase to the CPB prime reduced CD production 
during both induction and reperfusion (Fig. 3) and 
coronary sinus plasma CD returned to control evels 
after aortic unclamping. 
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Fig. 3. A, Myocardial CD production during BCP induction and reperfusion B.ReO~ Reoxygenation (see 
text for description). 
Biochemistry results 
Antioxidant reserve capacity. Antioxidant reserve 
capacity remained at control evels in nonhypoxemic 
piglets undergoing CPB and 30 minutes of aortic 
clamping with BCP, whereas 86% -+ 14% more 
malendialdehyde was produced than control values 
after incubation with 4 mmol t-butylhydroperoxide 
after reoxygenation with the same myocardial man- 
agement protocol in untreated piglets (Fig. 4). In 
contrast, post-CPB values for antioxidant reserve 
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Fig. 4. Antioxidant reserve capacity measured after 30-minutes post-CPB observation period. ReO~ 
Reoxygenation. 
capacity after reoxygenation with an extracorporeal 
circuit primed with N-(2-mercaptopropionyl)-gly- 
cine and catalase were comparable with those in 
nonhypoxemic piglets undergoing the same BCP 
protocol. 
Discussion 
These data provide further confirmation of the 
role of reoxygenation injury in previously hypoxemic 
hearts in the pathogenesis of postbypass dysfunc- 
tion 8 in the setting of an otherwise safe method of 
myocardial management during aortic clamping. 22 
A brief (i.e., 5 minutes) interval of reoxygenation  
CPB caused sufficient oxidant damage to nullify the 
cardioprotective effects of an otherwise safe BCP 
strategy. 3°These deleterious consequences of reoxy- 
genation could be offset substantially by adding 
antioxidants to the priming fluid of the extracorpo- 
real circuit to counteract the oxidant stress of abrupt 
reoxygenation. 
Background. Chronic cyanosis depletes the hu- 
man myocardium of endogenous antioxidant en- 
zyme activity (i.e., glutathione peroxidase and super- 
oxide dismutase [SOD]) 12 despite several metabolic 
adaptations, 31 which maintain aerobic metabolism 
in cyanotic myocardium. These biochemical conse- 
quences of hypoxemia can be reproduced experi- 
mentally in the acute setting 1° and may contribute to 
the vulnerability of chronic cyanotic hearts to intra- 
operative aortic clamping as shown both experimen- 
tally and clinically. 1-3 The aforementioned observa- 
tions led us to speculate that reduced endogenous 
antioxidant defenses may reduce the threshold for 
triggering oxidative injury when a burst of oxygen 
free radicals occurs when CPB is initiated in previ- 
ously cyanotic hearts and thereby potentially limit 
the cardioprotective and resuscitative effects of ef- 
ficient myocardial management techniques during 
aortic clamping. 27 The adverse mechanical conse- 
quences of reoxygenation are perhaps most evident 
from reports of myocardial dysfunction progressing 
to myocardial stunning (no aortic pulsations) after 
cyanotic infants are placed on extracorporeal oxy- 
genation for pulmonary disorders, because they 
occur without superimposed surgical ischemia) 2 
These observations lead us to suspect an even 
greater oxidant challenge to occur in cyanotic pa- 
tients who require surgical ischemia during intraop- 
erative repair and may therefore contribute to their 
higher morbidity and mortality compared with non- 
hypoxemic patients undergoing similar myocardial 
management techniques. 5-7 
The myocardial management s rategy of gluta- 
mate/aspartate-enriched BCP is an experimentally 
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sound and clinically relevant method of preventing 
ischemic damage in adult and pediatric patients that 
also resuscitates nergy and substrate-depleted h arts 
subjected to ischemic/reperfusion njury. 22' 26, 29, 33 Its 
ineffectiveness to reverse hypoxemic/reoxygenation 
damage was an unexpected finding and may be the 
result of the more severe oxidant stress imposed by 
reoxygenation versus reperfusion, as shown recently. 34 
The pathophysiology of reoxygenation a d reperfusion 
damage differs in that hypoxemia washes away reduc- 
ing equivalents (lactate) that may counteract oxidant 
damage during reperfusion 35so that the consequences 
of superimposed ischemia/reperfusion stress become 
amplified when the aorta is clamped immediately after 
reoxygenation  CPB. In this study CD production 
was lower during warm reperfusion than during warm 
induction, and the post-CPB reduction of antioxidant 
reserve capacity was similar to that observed in our 
previous tudy of reoxygenation  CPB without su- 
perimposed ischemia) ° These observations suggest 
that the cardioprotective effect of the myocardial man- 
agement strategy to "prevent" ischemic damage was 
retained but that reoxygenation i jury limited its ca- 
pacity to reverse the damage produced by reintroduc- 
tion of molecular oxygen. 
The most pronounced evidence of lipid peroxida- 
tion (CD production) occurred during warm BCP 
induction 5 minutes after reoxygenation on CPB. 
We suspect he delayed sampling (until CBF was 
controlled during cardioplegic administration) led 
to a systemic underestimation f oxidant damage, 
which likely followed the burst of free radical activ- 
ity immediately on reintroduction of molecular ox- 
ygen 36-3s when CPB was started. Studies of oxidant 
damage during ischemia/reperfusion show a rapid 
buildup of products of lipid peroxidation on reoxy- 
genation, with subsequent tissue depletion, 39 and 
yet plasma CDs in coronary sinus blood did not 
increase until 35 minutes of reoxygenation on by- 
pass. We suspect hat CBF autoregulated from the 
initial hyperemic phase, thereby accounting for a 
higher plasma concentration despite evidence of 
reduced production during myocardial management 
with BCP. Alternatively, the cessation of the car- 
dioplegic infusion provided by BCP protection may 
have allowed a resurgence of oxidant damage when 
unmodified blood was restored when the aorta was 
unclamped. Unfortunately, serial myocardial biopsy 
samples were not obtained and CBF was not mea- 
sured either immediately before or after aortic 
clamping and unclamping to allow determination of
which explanation was correct. 
The antioxidants N-(2-mercaptopropionyl)- 
glycine and catalase were selected for Study because 
of our prior experience with their effectiveness in
limiting reoxygenation damage in the absence of 
superimposed surgical ischemia. 8 N-(2-mercapto- 
propionyl)-glycine is an .OH scavenger that also 
counteracts hypochloric acid produced by activated 
neutrophils and impedes the cytotoxic effects of 
reactive oxygen intermediates that cause lipid per- 
oxidation and protein thiol oxidation. 17 This sub- 
stance also may interfere with oxidant damage via 
the e-arginine--NO pathway because of its action on 
peroxynitrite (OONO-). 40 Catalase scavenges H202 
radicals, which have deleterious effects other than 
via iron-catalyzed hydroxyl radical formation, in- 
cluding production of thromboxine A2 is and myo- 
globin-H202-induced oxidants. 17 The combined 
effects of N-(2-mercaptopropionyl)-glycine a d 
catalase in reducing lipid peroxidation, retarding 
depletion of antioxidant reserve capacity, and im- 
proving functional recovery after reoxygenation are 
consistent with similar benefits in the ischemic/ 
reperfusion model. 14' 15 
The results imply that assurance of satisfactory 
blood concentration of antioxidants at the initiation 
of reoxygenation counteracted the oxidant damage 
that otherwise would have occurred and allowed 
the cardioprotective effects of the myocardial man- 
agement echnique to remain operative. Clearly, 
alternative antioxidant approaches (deferoxamine, 
COQlo, SOD, allopurinol, etc.) may also limit reoxy- 
genation damage, but the experimental design was 
intended to establish the role of antioxidants in the 
CPB prime rather than to compare different com- 
pounds with alternate mechanisms of action. 
Reoxygenation damage is a biologic phenomena 
that is not confined to the myocardium. The current 
findings of increased PVRI in nonhypoxemic piglets 
after CPB were shown previously 41 and may reflect 
both the recognized adverse consequences of 
CPB in activating complement, 6'42 neutrophils, 43
the arachidonic acid pathway, 44 and ischemic/reper- 
fusion damage because pulmonary blood flow is 
diverted from the lung during cardiopulmonary b - 
pass and restored when CPB is discontinued. 
Reoxygenation caused a further augmentation of
PVRI (Fig. 2), which suggests that reoxygenation- 
induced endothelial damage may have occurred. 
Both H202 and subsequent -OH production may be 
principal effectors of endothelial dysfunction and 
subsequent morphologic disruption, 45 because re- 
cent studies 46 show that a brief exposure to H202 
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causes dose-dependent impairment of in vitro pul- 
monary artery endothelial cell function. Our find- 
ings that PVRI returned to near normal evels after 
N-(2-mercaptopropionyl)-glycine and catalase may 
indicate that the noncardiac effects of ischemia/ 
reperfusion and hypoxemia/reoxygenation were 
counteracted bythese antioxidants. Transient post- 
CPB pulmonary endothelial dysfunction raises 
PVRI by impairing release of endogenous endothe- 
lial-derived relaxation factor, thereby explaining 
why inhaled nitric oxide can reduce PVRI in post- 
cyanotic patients undergoing surgical correction of 
congenital defects causing cyanosis. 47 The control 
data in nonhypoxemic piglets provide further 
evidence of the cardioprotective effects of hypocal- 
cemic solutions in the immature heart. 48'49 The 
beneficial effects of selected antioxidants N-(2-mer- 
captopropionyl)-glycine a d catalase on reoxygenation 
damage are consonant with their usefulness in the 
ischemic/reperfusion model 14' 15 in that N-(2-mer- 
captopropionyl)-glycine and catalase-treated piglets 
showed less evidence of lipid peroxidation and expen- 
diture of antioxidant reserve capacity and better func- 
tional recovery than occurred in untreated piglets 
undergoing a comparable myocardial management 
protocol. 
The questionable r levance of the acute hypox- 
emic model to clinical chronic cyanosis is ac- 
knowledged, but our findings are consistent with 
reports in chronic cyanotic animals 3 and in hypox- 
emic patients undergoing surgical repair. 1' 11, 12, so 
Our quantification of myocardial dysfunction by 
inscribing pressure-volume loops appears incon- 
sistent with clinical observations of "uneventful 
recovery" in cyanotic patients (i.e., pulmonary 
stenosis or atresia and ventricular septal defect) 
who undergo surgical repair after a brief period of 
CPB. Temporary mild inotropic support is, how- 
ever, somewhat routine after surgery despite the 
brief period of bypass. Extracorporeal circulation 
could be discontinued in all piglets without ino- 
tropic support, and myocardial depression was 
quantified by the more comprehensive method of 
inscribing pressure-volume loops that is not ap- 
plied clinically. Furthermore, we did not adminis- 
ter inotropic drugs to determine if normal func- 
tion could be restored to match the routine 
perioperative management. We conclude that 
reoxygenation injury may add an otherwise avoid- 
able incremental adverse factor to the surgical 
correction of congenital defects causing cyanosis, 
because both the duration of CPB and surgical 
ischemia may be prolonged uring repair of con- 
genital defects. However, extrapolation of these 
findings to clinical events will require study in 
chronic animals, as well as quantification of the 
markers of lipid peroxidation and reduced antiox- 
idant reserve capacity in cyanotic patients placed 
on CPB. 
The findings of these short-term experiments 
showing that reoxygenation i jury can nullify the 
cardioprotective effects of an otherwise safe myocar- 
dial management technique and that adverse car- 
diac and pulmonary effects of reoxygenation can be 
counteracted bysupplementation of the extracorpo- 
real prime with antioxidants will hopefully lead to 
increased appreciation that the initiation of CPB in 
hypoxemic nfants may not be an innocuous event. It 
can produce adverse changes that could be modified 
by better understanding of the pathophysiology of 
reoxygenation injury. 
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